Compounds > mycarose
Page last updated: 2024-12-08

mycarose

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

mycarose: RN given refers to (L-ribo)-isomer; structure given in first source; epi-axenose to lyxo configeration [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID169005
CHEBI ID31010
SCHEMBL ID489381
MeSH IDM0133083

Synonyms (25)

Synonym
CHEBI:31010
3-epi-axenose
6032-92-4
2,6-dideoxy-3-c-methyl-l-ribo-hexose
mycarose
(3r,4s,5s)-3,4,5-trihydroxy-3-methylhexanal
2,6-dideoxy-3-c-methyl-lyxo-hexose
unii-21mjv8677v
l-ribo-hexose, 2,6-dideoxy-3-c-methyl-
21mjv8677v ,
2,6-dideoxy-3-c-methyl-ribo-hexose
mycarose [mi]
2,6-dideoxy-3-c-methyl-l-ribohexose
SCHEMBL489381
unii-i71i3dg1w1
I71I3DG1W1 ,
92345-04-5
mycarose dl- form [mi]
mycarose, (+/-)-
mycarose, dl-
ribo-hexose, 2,6-dideoxy-3-c-methyl-
Q27114061
DTXSID30975732
2,6-dideoxy-3-c-methylhexose
AKOS040753173
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
dideoxyhexose derivativeA deoxyhexose derivative that is formally obtained from a dideoxyhexose.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (12.50)18.7374
1990's3 (18.75)18.2507
2000's10 (62.50)29.6817
2010's1 (6.25)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.10

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.10 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.10)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
thymidine
[no description available]		7.0310pyrimidine 2'-deoxyribonucleosideEscherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite
erythromycin
Erythromycin: A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.. erythromycin : Any of several wide-spectrum macrolide antibiotics obtained from actinomycete Saccharopolyspora erythraea (formerly known as Streptomyces erythraeus).. erythromycin A : An erythromycin that consists of erythronolide A having 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl and 3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl residues attahced at positions 4 and 6 respectively.		8.2760cyclic ketone;
erythromycin
galactose
aldohexose : A hexose with a (potential) aldehyde group at one end.		4.14160
glucose-1-phosphate
glucose-1-phosphate: RN given refers to (alpha-D-Glc)-isomer. alpha-D-glucose 1-phosphate : A D-glucopyranose 1-phosphate in which the anomeric centre has alpha-configuration.		7.0310D-glucopyranose 1-phosphate
mycaminose
[no description available]		2.0810deoxyglucose derivative;
glucosamines
desosamine
desosamine: RN given for (D-xylo)-isomer; structure in first source		7.730amino sugar
glucosamine
D-glucosamine : An amino sugar whose structure comprises D-glucose having an amino substituent at position 2.. 2-amino-2-deoxy-D-glucopyranose : A D-glucosamine whose structure comprises D-glucopyranose having an amino substituent at position 2.		2.0810D-glucosamineEscherichia coli metabolite;
geroprotector;
mouse metabolite
erythronolide b
[no description available]		2.0310erythronolide
glycosides
[no description available]		210
erythronolide a
erythronolide A: structure in first source		2.0310erythronolide
hygromycin a
hygromycin A: a cinnamide derivative produced by Streptomyces hygroscopicus; structure differs from HYGROMYCIN B		210hydroxycinnamic acidmetabolite
vicenistatin
vicenistatin: a macrocyclic lactam from Streptomyces sp. HC34; structure given in first source		210azamacrocycle;
lactam
carbomycin
carbomycin: from Streptomyces halstedii		710
olivose
olivose: RN given for (D)-isomer		2.4420hexose
hygromycin b
[no description available]		210
tylosin
[no description available]		2.4120
ConditionIndicatedRelationship StrengthStudiesTrials